Read Research Alzheimer's More' title='Share this by email.' class='social email'>           

Validating Alzheimer's disease micro RNAs using next-generation sequencing

Molecular biomarkers for Alzheimer’s disease (AD) can support detection and improved care for patients, but novel candidates require verification. We previously reported a 12-micro RNA (miRNA) blood-based signature using next-generation sequencing (NGS) of 54 AD cases and 22 controls. Read & Research Alzheimer’s More

Leave a Reply